Omni Health Inc (OMHE)

[BubbaInSC]

LMAO - Again, Your Excuse For VTCQs failure to produce respectable revenues domestically and overseas means nothing since the information did not come a respectable, reliable source such as Marketwired. It really is as simple as that.

Fact: MCIG/VTCQ had a contract with Koolever back in October 2014

10/21/14
http://globenewswire.com/news-release/2014/10/21/674921/10103525/en/mCig-R-Inc-and-Omnicam-Execute-Landmark-Distribution-Agreement-for-VitaCig-R-Covering-South-Korea-Company-Raises-Full-Year-Guidance.html

VitaCig, Inc. has executed a historic distribution agreement awarding San Francisco based Omnicam and its Korean partner Kooleever Inc. with exclusive rights to distribute VitaCig® products in the Republic of Korea in territories covering a population of 50 million people. Koolever has already contracted with over 160 stores that will begin retailing the VitaCig® units over the next few weeks. Additional stores are expected to come on-line in December 2014.

The Omnicam agreement is part of a comprehensive effort by the company to lock-in international distribution agreements. The effort has been spear-headed by Paul Rosenberg. Our agreement with Omnicam, Koolever, David Choi, and Tom Choi is the most important event in the history of the company and we are honored to have earned their trust.

You have ZERO evidence to show that the original contract became null and void after a customs hickup.


What facts do I have to support the opinion that the old contract existed? Well, the continued growth of Korean retailers and the existing operation of a VitaCig Korea website has been in operation since the customs hickup.

So, how do we know VTCQ USA and MCIG USA didn't get anything for all of those Vitastik sales? Well, gee - no commissions were ever accounted for in VTCQ USAs top line, nor was it accounted for on MCIGs top line.

VitaStiks were not mentioned, not only in the PR VitaCig EU Contract, but it wasn't mentioned in the new VitaCig Korea contract PR either.

That was on purpose! VitaStiks weren't mentioned because it's not a CBD product; which is specifically covered under the new contracts.

So, yeah. No commissions from VitaCig EU or VitaCig Korea before the new contract. And 0% commission from overseas sales of VitaStiks going forward until the old contract runs out.

Again, not sure why people are afraid of admitting that the VitaStik is being used as a "loss leader" product overseas until the old contracts expire.

As a trader, I would want the International partners to place orders for all CBD products and not VitaStiks. Could care less about the VitaStiks internationally until the old contracts expire because it doesn't grow VTCQ USA's top line.

It's crystal clear at this point.

BTW, 30k units of vitastiks nets a likely 0% commission for VTCQ USA; if it's for vitastiks.

Another vague PR from Paul that was intentional.

On a side note, here's a quote from a different poster

10/12/2015
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117660502

That joke seems all the more real following
the customs snafu.

I'd say the South Korean deal is a monumental
success.
Considering the Vitastik product can now
be found in over 186 locations.
And has likely reordered during this Quarter.
With South Korean partner landing the
new Japanese deal.
Which we will hear more about soon enough.

The Omnicam deal, was delayed, but not denied!

Not a success for overseas sales of VitaStiks for VTCQ USA or MCIG USA

If what I've written is "not true" why don't you speak to your buddy Paul and have him release information in another PR that is published from a source like Marketwired?